Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Nele

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
ACS Nano|December 8, 2020
Controlled Dendrimersome Nanoreactor System for Localized Hypochlorite-Induced Killing of BacteriaMichael Potter, Adrian Najer, Anna Klöckner, et al.
Pharmacological Research|November 4, 2024
Nanoparticles encapsulating phosphatidylinositol derivatives promote neuroprotection and functional improvement in preclinical models of ALS via a long-lasting activation of TRPML1 lysosomal channelValentina Tedeschi, Valeria Nele, Valeria Valsecchi, et al.
Advanced Healthcare Materials|December 11, 2025
Ultrasound-Triggered Gelation for Restoring Biomechanical Properties of Degenerated Functional Spinal UnitsVeerle A Brans, Anna P Constantinou, Matthew J Kibble, et al.
Molecular Therapy. Nucleic Acids|February 25, 2026
Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccinationArianna De Chiara, Valeria Nele, Alessia Angelillo, et al.
Molecular Therapy. Nucleic Acids|July 14, 2023
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancerMarianna Abate, Angela Lombardi, Amalia Luce, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2024
Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomideMarianna Abate, Manuela Porru, Virginia Campani, et al.
Cancers|September 28, 2024
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept StudyLuisa Amato, Caterina De Rosa, Viviana De Rosa, et al.
International Journal of Molecular Sciences|July 29, 2025
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune SystemHamid Heydari Sheikhhossein, Luisa Amato, Viviana De Rosa, et al.
Communications Biology|October 30, 2024
Author Correction: Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growthRossella Delle Donne, Rosa Iannucci, Laura Rinaldi, et al.
Communications Biology|August 2, 2022
Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growthRossella Delle Donne, Rosa Iannucci, Laura Rinaldi, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
ACS Nano|December 8, 2020
Controlled Dendrimersome Nanoreactor System for Localized Hypochlorite-Induced Killing of BacteriaMichael Potter, Adrian Najer, Anna Klöckner, et al.
Pharmacological Research|November 4, 2024
Nanoparticles encapsulating phosphatidylinositol derivatives promote neuroprotection and functional improvement in preclinical models of ALS via a long-lasting activation of TRPML1 lysosomal channelValentina Tedeschi, Valeria Nele, Valeria Valsecchi, et al.
Advanced Healthcare Materials|December 11, 2025
Ultrasound-Triggered Gelation for Restoring Biomechanical Properties of Degenerated Functional Spinal UnitsVeerle A Brans, Anna P Constantinou, Matthew J Kibble, et al.
Molecular Therapy. Nucleic Acids|February 25, 2026
Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccinationArianna De Chiara, Valeria Nele, Alessia Angelillo, et al.
Molecular Therapy. Nucleic Acids|July 14, 2023
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancerMarianna Abate, Angela Lombardi, Amalia Luce, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2024
Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomideMarianna Abate, Manuela Porru, Virginia Campani, et al.
Cancers|September 28, 2024
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept StudyLuisa Amato, Caterina De Rosa, Viviana De Rosa, et al.
International Journal of Molecular Sciences|July 29, 2025
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune SystemHamid Heydari Sheikhhossein, Luisa Amato, Viviana De Rosa, et al.
Communications Biology|October 30, 2024
Author Correction: Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growthRossella Delle Donne, Rosa Iannucci, Laura Rinaldi, et al.
Communications Biology|August 2, 2022
Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growthRossella Delle Donne, Rosa Iannucci, Laura Rinaldi, et al.
Pageof 4